New York software company One Drop added a Bluetooth-connected device developed by Westlake Village biotech MannKind to its platform Aug. 5. The device, called BluHale, allows users of the company’s flagship inhalable insulin product Afrezza to monitor their inhalations and their insulin dose. Through a collaborative agreement between the two companies, they will now have…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
